Merck inks $200 million deal for Hengrui's midstage heart disease drug
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Subscribe To Our Newsletter & Stay Updated